The blaKPC–2 and blaKPC–55 genes were amplified from the total DNA of K. pneumoniae KP1559 and BS407, respectively, using KPC_F (5′-AGGAGGTAAATAATGTCACTGTATCGC CGTCTAGTT-3′) and KPC_R (5′-TTACTGCCCGTTGACGCCCAA-3′) using Phusion® High-Fidelity DNA polymerase (Thermo Fisher Scientific, Waltham, MA, United States). Each PCR product was purified and cloned into the pCR-Blunt vector (Invitrogen, Thermo Fisher Scientific). The recombinant plasmids were transformed into chemically competent E. coli One ShotTM TOP10 (Invitrogen, Thermo Fisher Scientific) and selected on MH agar containing kanamycin 50 μg/ml and ampicillin 50 μg/ml. Nucleic acid sequences and the direction of each insert were verified by Sanger sequencing using the universal M13 primers of both directions.
Do you have any questions about this protocol?
Post your question to gather feedback from the community. We will also invite the authors of this article to respond.